| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Feb 4, 2025 | aTYR PHARMA INC | CFO | Sell | 47.5 | -1,254 | -3.80% | ✗ | $4.7K |
| May 31, 2024 | Jun 3, 2024 | aTYR PHARMA INC | CFO | Buy | 90.0 | +5,000 | 21.78% | ✗ | $9K |
| Feb 5, 2024 | Feb 6, 2024 | aTYR PHARMA INC | CFO | Sell | 47.5 | -1,590 | -7.09% | ✗ | $2.7K |
| Feb 3, 2023 | Feb 6, 2023 | aTYR PHARMA INC | CFO | Sell | 47.5 | -1,566 | -9.20% | ✗ | $3.7K |
| Jan 13, 2022 | Jan 18, 2022 | aTYR PHARMA INC | CFO | Buy | 91.3 | +1,923 | 18.87% | ✗ | $13K |
| Feb 6, 2021 | Feb 9, 2021 | aTYR PHARMA INC | CFO | Sell | 47.5 | -390 | -3.81% | ✗ | $3K |
| Jun 19, 2020 | Jun 23, 2020 | aTYR PHARMA INC | CFO | Buy | 90.0 | +1,850 | 25.33% | ✗ | $7.8K |
| Feb 6, 2020 | Feb 7, 2020 | aTYR PHARMA INC | CFO | Sell | 47.5 | -375 | -5.00% | ✗ | $1.5K |
| Sep 19, 2018 | Sep 21, 2018 | aTYR PHARMA INC | CFO | Buy | 95.0 | +64,000 | 246.15% | ✗ | $52.9K |
| Sep 14, 2018 | Sep 18, 2018 | aTYR PHARMA INC | CFO | Buy | 91.3 | +26,000 | 100.00% | ✗ | $19.1K |